Notice ID: a29e810deec3495dbad1d9c24ef6381ePresolicitationArchived
6515--Notice of Intent to Sole Source NX EQ Cryotherapy Systems: Tissue Ablation – Cardiac
Archived on May 8, 2026. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 10:00 AM EDT
- Posted
- April 23, 2026
- Notice type
- Presolicitation
Notice details
- Office
- SAC FREDERICK (36C10X)
- Place of performance
- Nationwide
- Last updated
- Oct 31, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- 36C10X26R0028
- Notice ID
- a29e810deec3495dbad1d9c24ef6381e
Description
Presolicitation Notice Presolicitation Notice Page 6 of 6 Presolicitation Notice *=Required Field Presolicitation Notice Page 1 of 6 The Department of Veterans Affairs (VA), Office of Procurement, Acquisition and Logistics, Strategic Acquisition Center (SAC), intends to award a sole source, firm fixed price requirements contract to Medtronic USA, Inc., 200 Medtronic Drive, Lafayette, CO 80026, for the procurement of the Medtronic Nitron CryoConsole Cardiac Cryoablation System, associated cryoballoon and focal catheters, installation, clinical and technical training, and OEM preventive maintenance and repair services. This action will support enterprise wide electrophysiology (EP) laboratory cardiac cryoablation capabilities across participating VA medical centers. The VA requires an FDA cleared, electrophysiology lab integrated cardiac cryoablation platform capable of performing both pulmonary vein isolation using cryoballoon catheters and focal cryoablation using OEM validated catheters on a single console. The system must include a cart based, closed loop nitrous oxide cryogen delivery console with real time pressure and temperature monitoring, automated safety interlocks, EP lab workflow integration, and compatibility with both cryoballoon and focal catheters from the same OEM. The platform must support facility installation, device qualification, staff training, and enterprise level OEM lifecycle service coverage to ensure safe, consistent operation across VA EP laboratories. Medtronic s Nitron CryoConsole, Arctic Front cryoballoon catheters, and Freezor focal catheters constitute the only FDA approved, OEM validated EP lab cryoablation ecosystem capable of meeting these requirements. Based on market research, including review of FDA cleared EP cryoablation technologies, available commercial systems, technical specifications, and current manufacturer product status, no other vendor produces an electrophysiology lab cryoballoon platform with a compatible focal catheter suite validated for use on a single console. No third party consoles or catheters are FDA validated for use with Medtronic s system, and use of non OEM components would fall outside FDA reviewed configurations. Accordingly, only Medtronic USA, Inc. can meet the VA s minimum clinical, enterprise standardization, and lifecycle sustainment requirements for an EP lab integrated cardiac cryoablation system. The applicable North American Industry Classification System (NAICS) code 339112 Surgical and Medical Instrument Manufacturing is most appropriate for this requirement. The size standard is 1,000 employees. The Product Service Code (PSC) is 6515 Medical and Surgical Instruments, Equipment, and Supplies. This notice of intent is not a request for competitive proposals. Interested parties may submit capability statements demonstrating that they can meet all of the Government s minimum requirements. Capability statements must include sufficient technical detail for consideration. The Government will review all responses received; however, a determination by the Government not to compete the proposed procurement based on any responses is solely within the Government s discretion. No solicitation is available at this time, and telephone inquiries will not be accepted. Points of contact are: Anthony Zibolski, Contracting Officer anthony.zibolski@va.gov Michael Andrews, Contract Specialist michael.andrews@va.gov
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Documents
Files (1)
- Download
36C10X26R0028.docx
20 KBAdded in Presolicitation version 3Posted
Lifecycle
- 3Version 3PresolicitationArchivedCurrent
6515--Notice of Intent to Sole Source NX EQ Cryotherapy Systems: Tissue Ablation – Cardiac
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Sources Sought Notice Sources Sought Notice Page 16 of 16 Sources Sought Notice *= Required Field Sources Sought Notice Page 1 of 16 REQUEST FOR INFORMATION 1. DESCRIPTION The Veterans Health Administration (VHA) Non-Expendable Equipment National Program has identified the Surgical Tissue Management System product line as a candidate for a VA-wide (otherwise referred to as national ) single Requirements contract award. The Department of Veterans Affairs (DVA) Office of Procurement, Acquisition and Logistics (OPAL) Strategic Acquisition Center (SAC) on behalf of VHA is issuing this Sources Sought Notice in accordance with the FAR 10.001(b) to determine the availability and technical capabilities of qualified sources. The SAC in conjunction with VHA is seeking a qualified source to provide Olympus ESG-410 brand name or equal for the Surgical Tissue Management System on an agency wide basis. VA intends to award a Requirements Contract with Firm-Fixed Price (FFP) orders IAW FAR 16.503, Requirements Contract to a supplier of this equipment. Vendors will be required to deliver the Surgical Tissue Management System to VA medical centers and facilities throughout the United States and its territories. The anticipated period of performance is for one (1) 12-month base period with four (4) 12-month option periods from the date of award. However, the Government's decision as to whether to continue with the contract, upon annual review, will be based upon successful performance during each previous year and continued need. The associated North American Industrial Classification System (NAICS) code for this procurement is 339112 - Surgical Appliance and Supplies Manufacturing, Product Service Code: 6515 Medical and Surgical Instruments, Equipment, and Supplies and the associated size standard is 1,000 employees. The FAR Provision found at 52.204-7(b)(1) requires that All interested Offerors must be registered in SAM.gov prior to submitting an offer or quotation. You may access the website at SAM.gov | Home. All offerors must be certified with the appropriate NAICS code on the SAM website. All SDVOSB/VOSB offerors must be verified in the SBA database at: https://veterans.certify.sba.gov/#search at the time of quote submission. This notice is for planning purposes only and does not constitute a commitment on the part of the Government to award a contract, nor does the Government intend to pay for any information submitted as a result of this notice. This Sources Sought Notice is part of a continuous process for obtaining the latest information on the commercial status of the industry with respect to their current and near-term abilities. The information provided herein is subject to change and in no way binds the Government to solicit for, or award, a competitive contract. It is emphasized that this is a notice solely for planning and informational purposes. 2. SCOPE OF WORK: The Veterans Health Administration (VHA) Non-Expendable Equipment National Program has identified the Surgical Tissue Management System product line as a candidate for a VA-wide (otherwise referred to as national ) Requirements contract. The Surgical Tissue Management System is an advanced, energy-based surgical platform used across Veterans Affairs Medical Centers (VAMCs) in operating rooms, procedural suites, and endoscopy units to perform precise tissue coagulation, devitalization, cutting, and vessel sealing. The system delivers radiofrequency (RF) energy and ultrasonic energy through specialized electrodes and hand instruments to support uniform, noncontact coagulation with minimal tissue penetration, improved visualization, and reduced bleeding. Units that provide both radio frequency power to drive electrosurgical instruments and mechanical vibrations to power ultrasonic surgical instruments used in the process of joining or sealing blood vessels together. The unit typically features receptacle ports, various output settings, power levels, and control mechanisms to adjust the energy delivered to the surgical site. It may also have features such as audible alarms, power monitoring, and temperature regulation. This universal platform provides multiple energy modalities (ultrasonic, bipolar, and RF) to support a broad range of open, laparoscopic, and endoscopic procedures in general surgery, urology, and gynecology, helping reduce the number of separate generators and instruments required in the operating room. It is designed to enhance surgical efficiency, improve hemostasis, and support consistent, replicable outcomes across diverse clinical applications The primary hand instrument is a hybrid ultrasonic and bipolar electrosurgical device intended for use in open and laparoscopic procedures to cut, seal, coagulate, and dissect with two distinct modes of action: Seal & Cut and Seal Only. It is indicated for ligation and division of vessels (up to and including 7 mm), lymphatics, and tissue bundles, and may be used in minimally invasive or open surgical procedures where vessel sealing and tissue division are desired. The device is intended for single use only and has not been shown to be effective for tubal sterilization or tubal coagulation for sterilization procedures. The Contractor must demonstrate the ability to meet all requirements for the solicitation. The objective is to provide Surgical Tissue Management Systems to be used by clinicians throughout the VA medical centers and facilities. The period of performance is for a base of 12-months with four 12-month option periods. 3. REQUIREMENT This requirement will be solicited and awarded as a Brand Name or Equal which requires the quoter indicate that each product being offered as an equal product to the Olympus ESG-410 Surgical Tissue Management System. For each equal product, the offeror must include a description reflecting the salient characteristics (SC) and level of quality that will satisfy the salient physical, functional, or performance characteristics of the equal product(s) specified in the solicitation. The quoter must also clearly identify the item by brand name (if any) and make/model number. Finally, the quoter must include descriptive literature, such as illustrations, drawings, or a clear reference to previously furnished descriptive data or information available to the Contracting Officer and clearly describe any modifications it plans to make to a product to make it conform to the solicitation requirements. Contract Line Items Manufacture Part Number Description Base Year Option Year 1 Option Year 2 Option Year 3 Option Year 4 001 Olympus WA91327U ESG-410 Surgical Energy Platform (SEP) 10 10 10 10 10 002 Olympus WA91302W Footswitch Double Pedaled, Wireless 10 10 10 10 10 003 Olympus WA91301W Footswitch Double Pedaled, Wired 10 10 10 10 10 004 Olympus WA95622A Power Cable, 4.5M, with angled plug 10 10 10 10 10 005 Olympus TC-E410 Cart 10 10 10 10 10 006 Olympus 784515 784515 PK FRONT LOADING SUPERSECT 5EA 10 10 10 10 10 007 Olympus WA22739S ESG PlasmaLoop - Long, Angled 10 10 10 10 10 008 Olympus WA22644S SP PlasmaNeedle - Long, Right-Angled 10 10 10 10 10 009 Olympus WA22742S ESG PlasmaLoop - Long, Small 10 10 10 10 10 010 Olympus WA22744S ESG PlasmaNeedle - Long, Right-Angled 10 10 10 10 10 011 Olympus WA22641S SP Plasma-OvalButton - Long 10 10 10 10 10 012 Olympus WA22666S SP Plasma-OvalButton 10 10 10 10 10 013 Olympus WA22741S ESG Plasma-OvalButton - Long 10 10 10 10 10 014 Olympus WA22766S ESG Plasma-OvalButton 10 10 10 10 10 015 Olympus 786500 786500 PK FRONT LOADING BUTTON 5EA 10 10 10 10 10 016 Olympus WA22657S SP PlasmaButton 10 10 10 10 10 017 Olympus WA22637S SP PlasmaLoop - Long, Medium 10 10 10 10 10 018 Olympus WA22638S SP PlasmaRoller - Long 10 10 10 10 10 019 Olympus WA22639S "SP PlasmaLoop - Long, Angled" 10 10 10 10 10 020 Olympus WA22737S ESG PlasmaLoop - Long, Medium 10 10 10 10 10 021 Olympus WA22738S ESG PlasmaRoller - Long 10 10 10 10 10 022 Olympus 784415 784415 FRONT LOADING SUPER-LOOP 5EA 10 10 10 10 10 023 Olympus WA22602S SP PlasmaLoop - Medium, 12 10 10 10 10 10 024 Olympus WA22603S SP PlasmaLoop - Large, 12 10 10 10 10 10 025 Olympus WA22606S SP PlasmaLoop - Medium, 30 10 10 10 10 10 026 Olympus WA22607S SP PlasmaLoop - Large, 30 10 10 10 10 10 027 Olympus WA22621S SP PlasmaBand - 12 10 10 10 10 10 028 Olympus WA22623S SP PlasmaBand - 30 10 10 10 10 10 029 Olympus WA22632S SP PlasmaLoop - Angled 10 10 10 10 10 030 Olympus WA22651S SP PlasmaRoller 10 10 10 10 10 031 Olympus WA22655S SP PlasmaNeedle - Angled 10 10 10 10 10 032 Olympus WA22605S SP PlasmaLoop - Small, 30 10 10 10 10 10 033 Olympus WA22702S ESG PlasmaLoop - Medium, 12 10 10 10 10 10 034 Olympus WA22703S ESG PlasmaLoop - Large, 12 10 10 10 10 10 035 Olympus WA22706S ESG PlasmaLoop - Medium, 30 10 10 10 10 10 036 Olympus WA22707S ESG PlasmaLoop - Large, 30 10 10 10 10 10 037 Olympus WA22721S ESG PlasmaBand - 12 10 10 10 10 10 038 Olympus WA22723S ESG PlasmaBand - 30 10 10 10 10 10 039 Olympus WA22732S ESG PlasmaLoop - Angled 10 10 10 10 10 040 Olympus WA22751S ESG PlasmaRoller 10 10 10 10 10 041 Olympus WA22755S ESG PlasmaNeedle - Angled 10 10 10 10 10 042 Olympus WA22760S ESG PlasmaButton 10 10 10 10 10 043 Olympus WA22640S SP PlasmaNeedle - Right-Angled 10 10 10 10 10 044 Olympus WA22642S SP PlasmaLoop - Long, Small 10 10 10 10 10 045 Olympus WA22705S ESG PlasmaLoop - Small, 30 10 10 10 10 10 046 Olympus WA22740S ESG PlasmaNeedle - Right-Angled 10 10 10 10 10 047 Olympus A22265C A22265C KNIFE 24-28FR 12/30 DEG 10 10 10 10 10 048 Olympus A22221C A22221C HF BAND 24 FR 12 DEG 10 10 10 10 10 049 Olympus A22257C A22257C HF CYL GROOVES 24-28FR 12/30DEG 10 10 10 10 10 050 Olympus WA22037C WA22037C HF LOOP 12DEG 12EA 10 10 10 10 10 051 Olympus WA22038C WA22038C HF ROLLER LONG 12DEG 12EA 10 10 10 10 10 052 Olympus WA22039C WA22039C HF ANGLED LOOP LONG 12EA 10 10 10 10 10 053 Olympus A22258C A22258C HF ROLLER LARGE 24-28FR 12/30DEG 10 10 10 10 10 054 Olympus A22205C A22205C HF LOOP 24FR .35 WIRE 30 DEG 10 10 10 10 10 055 Olympus A22261A A22261A CURETTE 24-28FR 12/30 DEG 10 10 10 10 10 056 Olympus A22201C A22201C HF LOOP 24FR .35 WIRE 12 DEG 10 10 10 10 10 057 Olympus A22201D A22201D HF LOOP 24 FR .2 WIR E 10 10 10 10 10 058 Olympus A22202C A22202C HF LOOP 26FR .35 WIRE 12 DEG 10 10 10 10 10 059 Olympus A22205D A22205D HF LOOP 24FR .2 WIRE 30 DEG 10 10 10 10 10 060 Olympus A22206C A22206C HF LOOP 26 FR .35 WIRE 30 DEG 10 10 10 10 10 061 Olympus A22231C A22231C HF ANGLED LOOP 24-28FR .35 WIRE 10 10 10 10 10 062 Olympus A22251C A22251C HF ROLLER 24-28FR 12/30DEG 10 10 10 10 10 063 Olympus A22253C A22253C HF NEEDLE 90 DEG 24-28FR 12DEG 10 10 10 10 10 064 Olympus A22255C A22255C HF 45DEG NEEDLE 24-28FR 12/30DEG 10 10 10 10 10 065 Olympus VE-B VE-B VaporTrode 10 10 10 10 10 066 Olympus VE-LG VE-LG VAPORTRODE GROOVED 10 10 10 10 10 067 Olympus VE-S VE-S Spiked VaporTrode 6EA 10 10 10 10 10 068 Olympus VE-F VE-F VAPORTRODE FLUTED BAR 10 10 10 10 10 069 Olympus MLE-24-010 MLE-24-010 CUTTING LOOP 12EA 10 10 10 10 10 070 Olympus MLE-24-012 MLE-24-012 CUTTING LOOP 12EA 10 10 10 10 10 071 Olympus MLE-24-015 MLE-24-015 CUTTING LOOP 12EA 10 10 10 10 10 072 Olympus MLE-26-010 MLE-26-010 CUTTING LOOP 12EA 10 10 10 10 10 073 Olympus MLE-26-012 MLE-26-012 CUTTING LOOP 12EA 10 10 10 10 10 074 Olympus MLE-26-015 MLE-26-015 CUTTING LOOP 12EA 10 10 10 10 10 075 Olympus MLE-28-012 MLE-28-012 CUTTING LOOP 12EA 10 10 10 10 10 076 Olympus MLE-28-015 MLE-28-015 CUTTING LOOP 12EA 10 10 10 10 10 077 Olympus MLES-24-015 MLES-24-015 CUTTING LOOP 12EA 10 10 10 10 10 078 Olympus RE-28 RE-28 ROLLER ELECTRODE 28FR 10 10 10 10 10 079 Olympus BE-208 BE-208 FULG ELECT LONG TIP 105CM 6EA 10 10 10 10 10 080 Olympus BE-202 BE-202 FULGUR ELECT SHORT TIP 105CM 6EA 10 10 10 10 10 081 Olympus KE-24 KE-24 ELITE KNIFE ELECTRODE 6EA 10 10 10 10 10 082 Olympus KE-28 KE-28 KNIFE ELECTRODE 10 10 10 10 10 083 Olympus RAK-26 RAK-26 RIGHT ANGLE KNIFE ELEC 6EA 10 10 10 10 10 084 Olympus RE RE ROLLER BALL 6 EA 10 10 10 10 10 085 Olympus BE-308 BE-308 FULGURATNG ELECT LG TIP 105CM 6EA 10 10 10 10 10 086 Olympus KE-26 KE-26 ELITE KNIVE ELECTRODE 26FR 6EA 10 10 10 10 10 087 Olympus 287 287 Flexible Electrode 10 10 10 10 10 088 Olympus BE-302 BE-302 FULGUR ELECT SHORT TIP 105 CM 6EA 10 10 10 10 10 089 Olympus A3559 A3559 KNIFE SEMI-CIRC FLEX TIP FOR A3550 10 10 10 10 10 090 Olympus RCE-336 RCE-336 RITECUT CUTTING ELECTRODE 10 10 10 10 10 091 Olympus RCE-3115 RCE-3115 RITECUT CUTTING ELECTRODE 10 10 10 10 10 092 Olympus DAC DAC ELITE & USA DISPOSABLE AC TIVE CORD 10 10 10 10 10 093 Olympus A3556 A3556 KNIFE SEMI-CIRC 4FR CHAN FOR A3550 10 10 10 10 10 094 Olympus A3555 A3555 KNIFE LANCET TYPE FOR A3550 10 10 10 10 10 095 Olympus A3557 A3557 KNIFE SERRATED FOR A3550 10 10 10 10 10 096 Olympus A3558 A3558 KNIFE SEMI-CIRCULAR FOR A3550 10 10 10 10 10 097 Olympus WA35057A WA35057A KNIFE SERRATED TYPE FOR A3550 10 10 10 10 10 098 Olympus 00107 00107 BUTTON ELECTRODE 4FR 10 10 10 10 10 099 Olympus 00108 00108 BUTTON ELECTRODE, 5FR 10 10 10 10 10 100 Olympus 00110 00110 BUTTON ELECTRODE, 7FR 10 10 10 10 10 101 Olympus 00111 00111 FLEX BUTTON ELECTRODE 8FR 10 10 10 10 10 102 Olympus A37020A A37020A PED HF ELECT BUTTON 3FR X 280MM 10 10 10 10 10 103 Olympus WA35055A WA35055A KNIFE LANCET CENTERED FOR A3550 10 10 10 10 10 104 Olympus 00109 00109 BUTTON ELECTRODE, 6FR 10 10 10 10 10 105 Olympus A0275 A0275 BUTTON ELECTRODE 9FR 10 10 10 10 10 106 Olympus A37010A A37010A PEDI KNIFE STRT FOR A37014A 10 10 10 10 10 107 Olympus A3753 A3753 LOOP ELECTRODE PEDIATRIC 10 10 10 10 10 108 Olympus A00010A A00010A HF CABLE UNIPOLAR 4M OLYMPUS 10 10 10 10 10 109 Olympus A00012A A00012A HF CABLE UNIPOLAR 4M VALLEYLAB 10 10 10 10 10 110 Olympus A37009A A37009A PEDIATRIC KNIFE HOOK FOR A37014A 10 10 10 10 10 111 Olympus A37011A A37011A PED HF RESECT ELECT FOR A37014A 10 10 10 10 10 112 Olympus A37013A A37013A PED HF ELECTRODE HOOK A37014A 10 10 10 10 10 113 Olympus WA00393S HF cable, monopolar, 4m single use 10 10 10 10 10 114 Olympus 253F6 253F6 FLEX FULG ELECT DOMED TIP 37 CM 10 10 10 10 10 115 Olympus 253F8 253F8 FLEX FULG ELECT SOMED TIP 37 CM 10 10 10 10 10 116 Olympus 256F6 256F6 FLEXIBLE FULG ELECT CON TIP 37CM 10 10 10 10 10 117 Olympus 256F8 256F8 FLEXIBLE FULG ELECT CON TIP 37CM 10 10 10 10 10 118 Olympus 257F6 257F6 FLEX ELECTRODE 10 10 10 10 10 119 Olympus 257F8 257F8 FLEX FULG ELECT BALL TIP 37 CM 10 10 10 10 10 120 Olympus A00011A A00011A HF CABLE UNIPOLAR 4M ERBE/MARTIN 10 10 10 10 10 121 Olympus ET ET TUBING FOR ELLIK/TOOMEY ADAPT 6EA 10 10 10 10 10 122 Olympus RAK-24 RAK-24 RIGHT ANGLE KNIFE ELEC 6EA 10 10 10 10 10 123 Olympus RB RB ROLLER BAR 6EA 10 10 10 10 10 124 Olympus 243 243 Flexible Bugbee Electrode, 37C M 10 10 10 10 10 125 Olympus 245 245 FLEX BALLENGER Follicle ELECT 37CM 10 10 10 10 10 126 Olympus WT630111 WT630111 Suction tube, for smoke evacuation 10 10 10 10 10 127 Olympus HYVV120 OR-VAC Surgical Smoke Evacuator 10 10 10 10 10 128 Olympus MAJ-1939 MAJ-1939 SMOKE EVACUATION FOOT SWITCH 10 10 10 10 10 129 Olympus TD-SB400 TD-SB400 SONICBEAT Transducer 10 10 10 10 10 130 Olympus SB-0520FC SB-0520FC (EN) SET (5PCS) 10 10 10 10 10 131 Olympus SB-0535FC SB-0535FC (EN) SET (5PCS) 10 10 10 10 10 132 Olympus SB-0545FC SB-0545FC (EN) SET (5PCS) 10 10 10 10 10 133 Olympus SB-0545PC SB-0545PC SONICBEAT 45cm, 5mm, pistol 10 10 10 10 10 134 Olympus PS-0523CJDA "POWERSEAL 5MM, 23CM, CURVED JAW SEALER 10 10 10 10 10 135 Olympus PS-0537CJDA "POWERSEAL 5MM, 37CM, CURVED JAW SEALER 10 10 10 10 10 136 Olympus PS-0544CJDA "POWERSEAL 5MM, 44CM, CURVED JAW SEALER 10 10 10 10 10 137 Olympus UHI-4 UHI-4 45L HIGHFLOW INSUFFLATION UNIT 10 10 10 10 10 138 Olympus WA90500US Pneumoliner Containment System 10 10 10 10 10 The Department of Veterans Affairs (VA) is seeking vendors who can provide Olympus ESG-410 Surgical Tissue Management System or equal as listed above which meet all the salient characteristics listed below. Vendors may quote any product solution or configuration so long as they meet the salient characteristics. Products quoted in the technical volume must be captured on the Vendor s pricing volume (Attachment A, Price Cost Schedule) of the solicitation. Vendors may quote any additional ancillary products which they deem to be essential to the functionality of the proposed solution; these items must be captured in the Vendor s pricing volume with a quantity of zero. CLIN s 0001-0005 apply to the following SC s SC # SALIENT CHARACTERISTICS METHOD OF EVALUATION SC Literature Map Olympus ECG-410 ConMed System SC 1 Must be cleared by the U.S. Food and Drug Administration (FDA) Literature Review FDA 510k look up search page 1 FDA 510k look up search page 1 SC 2 Must provide Hybrid Energy, Advanced Bipolar, Ultrasonic Energy, Monopolar and Bipolar, Plasma energy types/modes Literature Review Instruction Manual Page 23 System 2450 user manual Page 2-3 SC 3 Must provide a centralized color touchscreen user interface that allows the operator to select, monitor, and adjust at minimum: Electrosurgical mode (e.g., monopolar cut, monopolar coag, bipolar); Output power settings (watts); Application-relevant parameters; and Treatment or activation time (timer or activation counters). Literature Review Instruction Manual page 2 System 2450 user manual Page 2-2 SC 4 Must have Contact quality monitoring (CQM) that detect these three types of insufficiencies regarding the neutral electrode. The neutral electrode is detaching from the patient. The neutral electrode is disconnected. Short circuit of the neutral electrode. Literature Review Instruction Manual Page 28 System 2450 user manual Page 2-7 SC 5 Must provide monopolar, bipolar and universal connection Literature Review Instruction Manual Page 23 System 2450 user manual Page 2-3 SC 6 Must provide both wireless and wired footswitch options Literature Review Instruction Manual Page 23 System 2450 user manual Page 2-3 SC 7 Must be compatible with smoke evacuation and insufflation systems Literature Review Instruction Manual Page 23 System 2450 user manual Page 2-3 SC 8 Output energy monopolar cut > 300W monopolar coag >200W bipolar cut > 100W (320 saline) bipolar coag > 120W (200 saline) Literature Review ECRI Market Intelligence Report Page 2 ECRI Market Intelligence Report Page 2 SC 9 Must include a minimum one year manufacturer warranty covering parts and labor Literature Review ESG-410 Urology Brochure Page 2 System 2450 user manual Page 2 Design Design features and functions of the offered device will be evaluated for its ability to aid in the performance of its intended function. Areas include but are not limited to the following: Ability to integrate with other Surgical Equipment Probe functions/versatility Customization for various procedures (options) Irrigation options/availability Number and variety of input/outputs connection/ports for peripheral devices Types of procedures supported Performance The Device will be evaluated for its ability to perform its intended function. Areas included but are not limited to: Touch Screen features and ease of use Workflow performance of complete system Types/modes of energy (above and beyond what is in the SCs) Power adjustability Safety The device will be assessed for patient safety features, including, but not limited to, the following areas: Audible tones and visual alarms Contact monitoring data display Quality/Service /Training Training - Availability and options Service - Terms and conditions Warranty Terms and conditions Again, for each product (brand name and part number), the response must include descriptive literature demonstrating the product meets or exceeds the salient characteristics specified above. The Government's intent is to include all ancillary items to ensure the equipment can function as designed by the Original Equipment Manufacturer (OEM) and as clinically required. Vendors are encouraged to provide any product solution or configuration so long as they meet the salient characteristics. Additionally, responses can include any additional product that may be beneficial. These items must be clearly identified by brand name and part number. Responses to this Sources Sought Notice shall include the following: Does vendor offer an annual service plan, Yes or No? If Yes: What does the plan cover? Does plan cover software updates only? Does the plan cover parts repair or replacement only? Does the plan cover both software and parts? Vendors are requested to provide documentation that shows information on their service plan. Is the service provided by the OEM or a subcontractor? Full name and address of company DUNS number/ CAGE Code/ SAM UIE Business Size Manufacturer or Distributor: If distributor - provide full name, business size and address of manufacturer. Country of Origin designation for all products Ability to provide uninterrupted supply of products on a national scale. Technical Literature that clearly shows product(s) meets the identified salient characteristics and page numbers where each salient characteristic is met. Any additional product solution or configuration that would be beneficial to the clinical functionality of the product line identified. Authorized Distributor Letter Certified by OEM with a current date. Although not required, vendors responding to this Sources Sought may also submit a Capabilities Statement. | 99% | Market Research | 04/06/2026 |
In accordance with FAR 13.106-1(b)/8.405-6(a)(2), this Notice of Intent is to inform all parties the Department of Veterans Affairs, Network Contracting Office (NCO) 19 located at 6162 South Willow Drive Suite 300, Greenwood Village, CO 80111 intends to award a sole source procurement for the following requirement to the large business manufacturer, Cadwell, located at 909 North Kellogg Street, Kennewick, WA 99336: ITEM # DESCRIPTION OF SERVICE QUANTITY UNIT OF ISSUE 0001 Cadwell Easy III PSG System Period of Performance: 9/30/2026 9/29/2027 4 EA The Fort Harrison VA Sleep Lab requires the replacement of the current polysomnography system that is discontinued and no longer supported. Replacement with the Cadwell III PSG system including amplifiers, cameras, acquisition workstations, scoring software, HL7 interfaces, installation, and training is required. Single-Source Justification Authority: FAR 6.302-1 Only One Responsible Source. 1. Basis for Single-Source Selection (Cadwell Industries, Inc.) Cadwell s Easy III PSG system is the only commercially available sleep system that meets all VA-defined salient characteristics, validated workflows, and network/security constraints documented in the Sleep Lab Deployment Guide v3.2. Cadwell Industries, Inc., (manufacturer) and Cadwell Laboratories, Inc. (serviceprovider) are collectively known as "Cadwell". Cadwell is the only authorized service provider of Cadwell products, including the Easy III PSG. As the manufacturer, and sole service provider, Cadwell trains and equips Technicians to perform all maintenance and repairs required for our products. There are no other entities in the United States that are authorized to provide service for Cadwell products. No other entities maintain technical support personnel who are regularly trained to service and maintain Cadwell products in accordance with our specifications. A. Proprietary amplifier design: The Easy III amplifier provides proprietary physiological channel integration, deterministic DSCP traffic behavior, and VA-approved firmware. B. HL7 workflow compatibility: Cadwell is the only vendor validated for HL7 V2.x MLLP messaging to the Compass Router (10.157.17.38) and VA-standard routing workflows. C. Infrastructure compatibility: Cadwell matches prior VISN deployments and requires no new training, security review, or workflow changes. D. Security and hardening: Cadwell is the only vendor that provided complete Defender exclusions, patch cycles, and hardening documentation. E. Salient characteristics compliance: Only Cadwell met all required signal channels, A/V sync, latency, VLAN/QoS requirements, and export format standards. 2. Summary of Market Research Findings: Four vendors were evaluated. Only Cadwell met 100% of mandatory requirements. Other vendors lacked validated HL7 workflows, proper QoS handling, or security documentation. 3. Impact of Not Using Cadwell: Attempting competition would delay deployment 12 18 months, increase costs, and introduce cybersecurity risk. 4. Fair and Reasonable Price: Pricing aligns with prior VISN purchases and historical benchmarks. Conclusion: Based on technical requirements, interoperability, security needs, and market research, Cadwell is the only responsible source capable of providing a compliant PSG system for the Fort Harrison VA Sleep Lab. FAR 6.302-1 single-source procurement is justified. The associated North America Classification Systems (NAICS) Code is 339112 and the Business Size Standard is 1,000 Employees. THIS NOTICE OF INTENT IS NOT A REQUEST FOR COMPETITIVE QUOTES. Interested parties may identify their interest and capability to respond to this requirement no later than 12:00 PM Local Mountain Time, Tuesday, September 22nd, 2026. Information received in response to this notice must clearly demonstrate the capability of meeting the Government s need as stated above. Include any relevant information (specifications, cut sheets, brochures, capability statement, etc.) confirming the ability to supply the products and/or any services outlined in this notice. Responses to this notice are to be sent to barron.long@va.gov. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. The Government is not responsible for any potential costs incurred from interested parties desiring to respond to this notice. | 80% | Special Notice | 09/22/2026 |
Request for Information 36C10X27Q0002 Department of Veterans Affairs (VA) Healthcare Technology Management (HTM) Inpatient Pharmacy Automation System (IPAS) suite and Automated unit dose repacking systems (Pill packaging system) Indefinite Delivery-Indefinite contract. THIS IS A REQUEST FOR INFORMATION (RFI) ONLY (as defined in FAR 15.101(c)), this is not a solicitation, a solicitation is not available at this time. Requests for a solicitation will not receive a response. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received, provide feedback to respondents with respect to any information submitted, or respond to any questions or comments that may be submitted in response to this RFI. This notice does not constitute a commitment by the United States Government and does not obligate the Government to award a contract or otherwise pay for the information provided in response. Responders are solely responsible for all expenses associated with responding to this RFI. The purpose of this RFI is for Market Research and to gather input for use in further defining the requirement only, and to identify interested and potentially capable vendors to fulfill requirements for: 1. An Indefinite Delivery-Indefinite contract for an enterprise procurement of Automated unit dose repacking systems (Pill packaging system) for inpatient pharmacies across the country. The procurement shall include the unit dose packager, supplemental lower packaging unit, tray system, cannisters, canister calibration system, all software and interfaces required to integrated into the existing pharmacy information system. The contract shall include all software and professional services required to install and operate the inpatient medication dispensing workflow to include interfaces, licenses, equipment relocations, enterprise reporting, and Electronic Health Record integration, as well as maintenance and support agreements. It shall include VHA personnel training, technology refreshes, upgrades, additional components, architecture enhancements and licensing support as needed. 2. An Inpatient Pharmacy Automation System (IPAS) suite across the country. The suite of equipment includes automation dispensing cabinets, IV prep systems, carousels, refrigerators, auxiliary equipment and accessories. The contract shall include all software and professional services required to install and operate the inpatient medication dispensing workflow to include interfaces, licenses, equipment relocations, enterprise reporting, and Electronic Health Record integration, as well as maintenance and support agreements. It shall include VHA personnel training, technology refreshes, upgrades, additional components, architecture enhancements and licensing support as needed. The Contractor shall provide all equipment, supplies, transportation, tools, materials, supervision, and other items and non-personal services necessary to install and support the inpatient pharmacy automation system as defined in this Performance Work Statement (PWS), except for those items specified as government furnished property and services. Additionally, the Government aims to determine if this can be fulfilled under a single vehicle for executing the proposed tasks would be a viable pathway. The details of the system’s requirements and capabilities are found in: Attachment A: Draft Performance Work Statement (PWS) - Automated Unit Dose Repacking Systems (Pill packaging system) Attachment B: Draft Performance Work Statement (PWS)- Inpatient Pharmacy Automation Dispensing System 1. Background VHA Office of Healthcare Technology Management (HTM), in conjunction with Pharmacy Benefits Administration (PBM), develops and guides the comprehensive management of pharmacy technologies to assure safe, available, and innovative medical technology used to deliver exceptional health care for Veterans. HTM/Biomedical Engineering at the medical facilities direct the medical equipment management program and support clinical care through providing preventive and corrective maintenance, healthcare consulting, and professional services for the technology assessment, implementation and sustainment of medical equipment and clinical systems. Planned Performance: End of First Quarter of Fiscal Year (FY) 27. * The information provided in the RFI is subject to change and is not binding on the Government. INSTRUCTIONS FOR RESPONDING TO THIS RFI CONFIDENTIALITY: No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s). Response Format/Page Limitations: In your capability statement, address how you would deliver/implement the specific tasks outlined in Attachment A and B. The overall total page limit for responses to this RFI is ten (10) pages. (Page count excludes – General Information). Responses should be submitted in Microsoft Word format with 12 pt. Vendors may also submit additional information not specifically requested above, which would provide value and insight to the Government. NO MARKETING MATERIALS ARE ALLOWED AS PART OF THIS RFI. Generic capability statements will not be accepted or reviewed. Your response must address capabilities specific to the services required in the attached draft Requirements Document. Please be advised that all submissions become Government property and will not be returned. Please provide an index to assist the Government in identifying where you have addressed each question below in your Capabilities Statement. Please provide question number corresponding page and section heading and/or paragraph number. General Information section shall include the following at a minimum: Name, mailing address, overnight delivery address (if different from mailing address), phone number, fax number, and e-mail of designated point of contact. Recommended Contract Type. Provide a recommended contract type and a justification supporting the use of a Firm-Fixed-Price (FFP) arrangement in lieu of a Labor-Hour (LH) contract. The Government’s preference is for an FFP contract; therefore, respondents are requested to explain how the requirement can be sufficiently defined, scoped, and managed to enable performance under an FFP structure. The response should describe the conditions, assumptions, and risk mitigation approaches that would support successful execution under an FFP contract. The number of pages in General Information Section shall not be included in the ten (10) page limit. The ten (10) page limit begins after the completion of General Information. Reference “36C10X27Q0002 - Automation Dispensing System and Pill Packager IDIQ” in the response and Subject Line of the email). Any organization responding to this notice should ensure that its response is complete and sufficiently detailed. Respondents are requested to limit responses to the information, and in the format provided below. Companies are encouraged to include any relevant information (specifications, cut sheets, brochures, capability statement, previous experience etc.) to confirm the company’s ability to meet the requirements outlined in this request. 2. GENERAL INFORMATION The following information is requested: Administrative Information: Company Name, mailing address, phone number, and e-mail of designated point of contact. Company Cage Code and Unique Entity Identifier (UEI). Companies must be registered in the System for Award Management (SAM, at www.sam.gov) to be considered as a potential source. Indicate the North American Industry Classification System (NAICS) code(s) under which your company typically performs Government contracts. Maximum participation by small businesses, including veteran-owned, service-disabled veteran-owned, HUBZone, small disadvantaged, and women-owned small business concerns, is encouraged. Suggested NAICS for this requirement is 339112 - Surgical and Medical Instrument Manufacturing. Identify the applicable SINs, including a description of each SIN’s product or service classification. Suggested PSC is 6515 - Medical and Surgical Instruments, Equipment, and Supplies. Small Business Designation status such as (8(a), HUBZone, Service-Disabled Veteran Owned Small Business (SDVOSB), Women-Owned, etc.). Business size status and time of last certification. The Government has not yet determined the set-aside capability. The results of this RFI will be used to assess small businesses’ capacity to fulfil this requirement and to inform the Government’s decision. Identify which pieces of equipment you offer or identify if you can supply the entire portfolio of products. Identify any contracting vehicles available to the Government for procuring this equipment and services (e.g., GSA PSS, GSA OASIS, NASA SEWP, etc.). This information is for market research purposes only and does not preclude your company from responding to this notice. Identify any products or services not manufactured in America. 3. CAPABILITY AND EXPERIENCE INFORMATION Company Qualifications: Describe your company’s capability to provide inpatient pharmacy automation systems to large, multi-facility healthcare enterprises, particularly within the Department of Veteran’s Affairs or other federal agencies. Provide examples of projects where you have successfully integrated your system with an Electronic Health Record (EHR) such as Oracle Health, MHS Genesis or other products. Please describe the hardware, software, and interface requirements to connect your systems with the EHR. Technical and System Capabilities-ADCs, Carousels, and IV prep: What are the underlying operating systems for your server and client-side equipment? Please confirm they meet the minimum requirements of Windows Server 2019 and Windows 11 or identify your plan and proposed timeline for moving to these operating systems. Does your latest system have a current Enterprise Risk Assessment (ERA)? If not, what is your plan and estimated timeline for obtaining one? Describe your system’s architecture. Is it a cloud-based, on-premises, or hybrid model? Describe the system's inherent capability to maintain data integrity and transaction continuity during degraded or disconnected network operations. What roles-based access are available to users? What functionality can the role-based access provide? Please provide the specifications of your IV prep system. Describe your system’s ability for a central pharmacy management or regional pharmacy management solutions—is it able to host individual sites to a single server located at another site—ie a single server to host 10+ facilities? 100+? Are there limitations to this set-up? Is there any cross functionality between the inpatient pharmacy automation suite and the supply automation suite? Can they leverage the same server or licenses? If yes, what options are available for supply automation suites? In the event of a power outage, what are the downtime protocols? If there is a mechanical failure, please describe if your equipment can function manually and the protocols for such. Are the packaging, labels and other consumables proprietary or are they available open market (assuming meets specifications company provides)? For your commercially available support agreement options, please provide information regarding service response times. Are parts available independent of whether a support agreement is in place? Are parts only support contracts available or the ability to schedule one-time repairs? Are there any equipment items or services that seem to be missing from the draft PWS? Are there requirements that are not applicable to the inpatient suite set up? Technical and System Capabilities-Pill packager: Provide your interface capabilities with inpatient automation vendors and identify whether this is one directional or bidirectional. What are the underlying operating systems for your server and client-side equipment? Please confirm they meet the minimum requirements of Windows Server 2019 and Windows 11 or identify your plan and proposed timeline for moving to these operating systems. Does your latest system have a current Enterprise Risk Assessment (ERA)? If not, what is your plan and estimated timeline for obtaining one? Describe your system’s architecture. Is it a cloud-based, on-premises, or hybrid model? Describe the system's inherent capability to maintain data integrity and transaction continuity during degraded or disconnected network operations. What roles-based access are available to users? What functionality can the role-based access provide? Please describe your cannister system and how new medications/new NDCs are configured? Can it be done locally or does it require sending back to the OEM? If it requires sending back to the OEM, what is the turnaround time options? What are the various sizes of cannisters and amount of cannisters available in each pill packaging unit? Are there recommendations by the vendor on which sized unit is needed where (ie if you do X, you should have at least Y size)? How many unit dose and multi-dose forms can be packaged per minute? Please describe your remote verification workflow. In the event of a power outage, what are the downtime protocols? If there is a mechanical failure, please describe if your equipment can function manually and the protocols for such. Are the packaging, labels and other consumables proprietary or are they available open market (assuming meets specifications company provides)? For your commercially available support agreement options, please provide information regarding service response times. What is the reported uptime of your system and how is it calculated? Are parts available independent of whether a support agreement is in place? Are parts only support contracts available or the ability to schedule one-time repairs? Are there any equipment items or services that seem to be missing from the draft PWS? Are there requirements that are not applicable to the inpatient pill packager? Demonstration Information: The Government requests that vendors offer a virtual demonstration on teams or another virtual meeting platform specified and approved by the government of their current operational, production ready inpatient automation dispensing cabinet suite solution pill packaging solution. The demonstration should, to the maximum extent possible, illustrate the end-to-end workflow used to support high-volume healthcare or enterprise correspondence processing. The demonstration should address the following capabilities, if available: New technologies offered in the last year Interfaces between other brands’ products Central Pharmacy Management from a single location or regional location Labeling abilities to support moderate sedation without automation Schedule for Demonstration 30-minute presentation technology and 30-minute demo with questions. Respondent must provide sides deck at least 24 hours before scheduled demonstration. Requesting demonstration between October 5 through 8, 2026, between 10:00AM-2:00PM EST. Please provide best date and time for demonstration. Email confirmation will be sent to each respondent to confirm date and time for demonstration. Interested firms are requested to provide Capability Statements addressing the following data/information requested by the closing date. In addition to providing your company’s capability statement as it pertains to the requirements of this RFI, interested and capable firms are also required to provide answers to the following questions. [ ] Yes [ ] No Does your company exceed the required number of employees/millions based on the appropriate NAICS the VA is requesting? [ ] Yes [ ] No Will at least 50 percent of the cost of performance incurred be expended for employees of your concern or employees of other eligible SDVOSB/VOSB concerns? 4.0 Responses THERE IS NO SOLICITATION AT THIS TIME. Responses to this notice are not offers and cannot be accepted by the U.S. Government to form a binding contract or agreement. This notice shall not be construed as a commitment by the Government to issue a solicitation, or ultimately award a contract, nor does it restrict the Government to a particular acquisition approach. The Government will in no way be bound to this information if any solicitation is issued. Submission of any information in response to this market survey is purely voluntary; the Government assumes no financial responsibility for any costs incurred. Your responses may be shared with all stakeholders, thus, information received will not be considered proprietary. 4.1. Responses: RFI responses are due no later than 10:00AM September 24, 2026, ET. Responses shall be submitted to: Contracting Officer – Caitlin Ruc at Caitlin.Ruc@va.gov and Contract Specialist – Tereshia Burford at Tereshia.Burford@va.gov. 4.2. Questions: No Questions are being accepted. Depending upon the responses received, VA may request additional information, may conduct future question and answer sessions, or may conduct meetings or an industry day. 52.215-3 Request for Information or Solicitation for Planning Purposes (Oct 1997) (a) The Government does not intend to award a contract based on this RFI or to pay for the information solicited except as an allowable cost under other contracts as provided in FAR subsection 31.205-18, Independent research and development and bid and proposal costs, of the Federal Acquisition Regulation. (b) Although “proposal” and “offeror” are used in this Request for Information, your response will be treated as information only. It shall not be used as a proposal. (c) This Request is issued for the purpose of: Information Purpose Only. (End of provision) Please see Attachments: A. DRAFT Performance Work Statement (PWS) - Automated unit dose repacking systems (Pill packaging system) B. DRAFT Performance Work Statement (PWS) - Inpatient Pharmacy Automation Dispensing System See Attachments for Complete detail of request. | 80% | Special Notice | 09/24/2026 |
The purpose of this amendment is to: Add VAAR Clause 852.219-76 to Section C Contract Clauses of Attachment A, RFP 36C10X26R0030_NX EQ Irrigation Systems for Endoscopy. C.11 852.219-76 VA Notice of Limitations on Subcontracting Certificate of Compliance for Supplies and Products (NOV 2022) As prescribed in 819.7011(c), insert the following clause. The contracting officer shall tailor the clause in paragraph (a)(2)(iii) as appropriate: VA Notice of Limitations on Subcontracting Certificate of Compliance for Supplies and Products (NOV 2022) (a) Pursuant to 38 U.S.C. 8127(k)(2), the offeror certifies that (1) If awarded a contract (see FAR 2.101 definition), it will comply with the limitations on subcontracting requirement as provided in the solicitation and the resultant contract, as follows: [Offeror check the appropriate box] (i) In the case of a contract for supplies or products (other than from a non-manufacturer of such supplies), it will not pay more than 50% of the amount paid by the government to it to firms that are not VIP-listed SDVOSBs as set forth in 852.219-73 or VOSBs as set forth in 852.219-74. Any work that a similarly situated VIP-listed subcontractor further subcontracts will count towards the 50% subcontract amount that cannot be exceeded. Cost of materials are excluded and not considered to be subcontracted. (ii) In the case of a contract for supplies from a nonmanufacturer, it will supply the product of a domestic small business manufacturer or processor, unless a waiver as described in 13 CFR 121.406(b)(5) is granted. The offeror understands that, as provided in 13 CFR 121.406(b)(7), such a waiver has no effect on requirements external to the Small Business Act, such as the Buy American Act or the Trade Agreements Act. (2) Manufacturer or nonmanufacturer representation and certification. [Offeror fill-in check each applicable box below. The offeror must select the applicable provision below, identifying itself as either a manufacturer or nonmanufacturer]: (i)  Manufacturer or producer. The offeror certifies that it is the manufacturer or producer of the end item being procured, and the end item is manufactured or produced in the United States, in accordance with paragraph (a)(1)(i). (ii)  Nonmanufacturer. The offeror certifies that it qualifies as a nonmanufacturer in accordance with the requirements of 13 CFR 121.406(b) and paragraph (a)(1)(ii). The offeror further certifies it meets each element below as required in order to qualify as a nonmanufacturer. [Offeror fill-in check each box below.] The offeror certifies that it does not exceed 500 employees (or 150 employees for the Information Technology Value Added Reseller exception to NAICS code 541519, which is found at 13 CFR 121.201, footnote 18). The offeror certifies that it is primarily engaged in the retail or wholesale trade and normally sells the type of item being supplied. The offeror certifies that it will take ownership or possession of the item(s) with its personnel, equipment, or facilities in a manner consistent with industry practice. (iii) The offeror certifies that it will supply the end item of a small business manufacturer, processor, or producer made in the United States, unless a waiver as provided in 13 CFR 121.406(b)(5) has been issued by SBA. [Contracting Officer fill-in or removal (see 13 CFR 121.1205). This requirement must be included for a single end item. However, if SBA has issued an applicable waiver of the nonmanufacturer rule for the end item, this requirement must be removed in the final solicitation or contract.] or [Contracting officer tailor clause to remove one or other block under subparagraph (iii).] If this is a multiple item acquisition, the offeror certifies that at least 50% of the estimated contract value is composed of items that are manufactured by small business concerns. [Contracting Officer fill-in or removal. See 13 CFR 121.406(d) for multiple end items. If SBA has issued an applicable nonmanufacturer rule waiver, this requirement must be removed in the final solicitation or contract.] (3) The offeror acknowledges that this certification concerns a matter within the jurisdiction of an Agency of the United States. The offeror further acknowledges that this certification is subject to Title 18, United States Code, Section 1001, and, as such, a false, fictitious, or fraudulent certification may render the offeror subject to criminal, civil, or administrative penalties, including prosecution. (4) If VA determines that an SDVOSB/VOSB awarded a contract pursuant to 38 U.S.C. 8127 did not act in good faith, such SDVOSB/VOSB shall be subject to any or all of the following: (i) Referral to the VA Suspension and Debarment Committee; (ii) A fine under section 16(g) (1) of the Small Business Act (15 U.S.C. 645(g)(1)); and (iii) Prosecution for violating section 1001 of title 18. (b) The offeror represents and understands that by submission of its offer and award of a contract it may be required to provide copies of documents or records to VA that VA may review to determine whether the offeror complied with the limitations on subcontracting requirement specified in the contract or to determine whether the offeror qualifies as a manufacturer or nonmanufacturer in compliance with the limitations on subcontracting requirement. Contracting officers may, at their discretion, require the contractor to demonstrate its compliance with the limitations on subcontracting at any time during performance and upon completion of a contract if the information regarding such compliance is not already available to the contracting officer. Evidence of compliance includes, but is not limited to, invoices, copies of subcontracts, or a list of the value of tasks performed. (c) The offeror further agrees to cooperate fully and make available any documents or records as may be required to enable VA to determine compliance. The offeror understands that failure to provide documents as requested by VA may result in remedial action as the Government deems appropriate. (d) Offeror completed certification/fill-in required. The formal certification must be completed, signed and returned with the offeror's bid, quotation, or proposal. The Government will not consider offers for award from offerors that do not provide the certification, and all such responses will be deemed ineligible for evaluation and award. Certification I hereby certify that if awarded the contract, [insert name of offeror] will comply with the limitations on subcontracting specified in this clause and in the resultant contract. I further certify that I am authorized to execute this certification on behalf of [insert name of offeror]. Printed Name of Signee: Printed Title of Signee: Signature: Date: Company Name and Address: (End of clause) | 76% | Combined Synopsis | 08/26/2026 |
NOTICE OF INTENT TO AWARD SOLE SOURCE: Department of Veterans Affairs (VA) Regional Procurement Office East (RPOE), Network Contracting Office 4 (NCO 4) intends to award a sole source procurement pursuant to RFO 6.103-1 to Simulab Corporation, located at 13001 48th Ave S, Tukwila, Washington, 98168. The VA Pittsburgh Healthcare System requires a Pacerman System with ultrasound for intravenous training. THIS NOTICE IS NOT A REQUEST FOR COMPETITIVE QUOTES; however, any responsible firm that believes it can meet the requirements may give written notification and capability statements prior to the response due date and time. Vendors shall indicate if they are the direct supplier or service provider of the items and/or authorized reseller/distributor. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to perform the requirements and must include relevant corporate experience along with the applicable contract number, total contract dollar amount, contract period of performance, details of the relevant services and customer point of contact with corresponding telephone number and email address. Responses must include following information: 1. Company Name 1. SAM number 1. Company’s address 1. Point of Contact information (title, phone number and email address) 1. Business size and socio-economic category, if applicable Response received will be evaluated; however, a determination by the Government not to compete the proposed procurement based on responses to this notice is solely within the discretion of the Government. Information provided will not be returned. Responses are due by Thursday, 11/12/2026 at 4:00 PM (EST). No submissions will be accepted after this date and time. Responses shall be submitted via email to Matthew.Clark11@va.gov The NAICS code for this acquisition is 339112 and the standard size is 1,000 employees. | 76% | Special Notice | 11/12/2026 |
Additional Details
Solicitation Number
36C10X26R0028
Archive Date
May 8, 2026
Office Address
FREDERICK, MD, 21703